86 related articles for article (PubMed ID: 15993506)
21. Hepatic damage caused by coxsackievirus B3 is dependent on age-related tissue tropisms associated with the coxsackievirus-adenovirus receptor.
Liu JY; Wang SM; Chen IC; Yu CK; Liu CC
Pathog Dis; 2013 Jul; 68(2):52-60. PubMed ID: 23620416
[TBL] [Abstract][Full Text] [Related]
22. An ERK-p38 subnetwork coordinates host cell apoptosis and necrosis during coxsackievirus B3 infection.
Jensen KJ; Garmaroudi FS; Zhang J; Lin J; Boroomand S; Zhang M; Luo Z; Yang D; Luo H; McManus BM; Janes KA
Cell Host Microbe; 2013 Jan; 13(1):67-76. PubMed ID: 23332156
[TBL] [Abstract][Full Text] [Related]
23. Porcine reproductive and respiratory syndrome virus replication is suppressed by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway.
Lee YJ; Lee C
Virus Res; 2010 Sep; 152(1-2):50-8. PubMed ID: 20540975
[TBL] [Abstract][Full Text] [Related]
24. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
[TBL] [Abstract][Full Text] [Related]
25. Functional Consequences of RNA 5'-Terminal Deletions on Coxsackievirus B3 RNA Replication and Ribonucleoprotein Complex Formation.
Lévêque N; Garcia M; Bouin A; Nguyen JHC; Tran GP; Andreoletti L; Semler BL
J Virol; 2017 Aug; 91(16):. PubMed ID: 28539455
[TBL] [Abstract][Full Text] [Related]
26. Tyrosine phosphorylation events during coxsackievirus B3 replication.
Huber M; Selinka HC; Kandolf R
J Virol; 1997 Jan; 71(1):595-600. PubMed ID: 8985388
[TBL] [Abstract][Full Text] [Related]
27. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
[TBL] [Abstract][Full Text] [Related]
28. The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus.
Martino TA; Petric M; Weingartl H; Bergelson JM; Opavsky MA; Richardson CD; Modlin JF; Finberg RW; Kain KC; Willis N; Gauntt CJ; Liu PP
Virology; 2000 May; 271(1):99-108. PubMed ID: 10814575
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of the extracellular signal-regulated kinase signaling pathway is correlated with proteasome inhibitor suppression of coxsackievirus replication.
Wong J; Zhang J; Si X; Gao G; Luo H
Biochem Biophys Res Commun; 2007 Jul; 358(3):903-7. PubMed ID: 17509528
[TBL] [Abstract][Full Text] [Related]
30. The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication.
Andrade AA; Silva PN; Pereira AC; De Sousa LP; Ferreira PC; Gazzinelli RT; Kroon EG; Ropert C; Bonjardim CA
Biochem J; 2004 Jul; 381(Pt 2):437-46. PubMed ID: 15025565
[TBL] [Abstract][Full Text] [Related]
31. Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells.
Werner B; Dittmann S; Funke C; Überla K; Piper C; Niehaus K; Horstkotte D; Farr M
Inflamm Res; 2014 Apr; 63(4):267-76. PubMed ID: 24316867
[TBL] [Abstract][Full Text] [Related]
32. Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway.
Si X; McManus BM; Zhang J; Yuan J; Cheung C; Esfandiarei M; Suarez A; Morgan A; Luo H
J Virol; 2005 Jul; 79(13):8014-23. PubMed ID: 15956547
[TBL] [Abstract][Full Text] [Related]
33. Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication.
Si X; Wang Y; Wong J; Zhang J; McManus BM; Luo H
J Virol; 2007 Apr; 81(7):3142-50. PubMed ID: 17229707
[TBL] [Abstract][Full Text] [Related]
34. Coxsackievirus B3 replication and pathogenesis.
Garmaroudi FS; Marchant D; Hendry R; Luo H; Yang D; Ye X; Shi J; McManus BM
Future Microbiol; 2015; 10(4):629-53. PubMed ID: 25865198
[TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of virus-host cell interactions of haemagglutinating and non-haemagglutinating strains of coxsackievirus B3.
Pasch A; Küpper JH; Wolde A; Kandolf R; Selinka HC
J Gen Virol; 1999 Dec; 80 ( Pt 12)():3153-3158. PubMed ID: 10567646
[TBL] [Abstract][Full Text] [Related]
36. 5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.
Kim KS; Tracy S; Tapprich W; Bailey J; Lee CK; Kim K; Barry WH; Chapman NM
J Virol; 2005 Jun; 79(11):7024-41. PubMed ID: 15890942
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of fatty acid synthase by amentoflavone reduces coxsackievirus B3 replication.
Wilsky S; Sobotta K; Wiesener N; Pilas J; Althof N; Munder T; Wutzler P; Henke A
Arch Virol; 2012 Feb; 157(2):259-69. PubMed ID: 22075919
[TBL] [Abstract][Full Text] [Related]
38. Cleavage of Grb2-Associated Binding Protein 2 by Viral Proteinase 2A during
Deng H; Fung G; Qiu Y; Wang C; Zhang J; Jin ZG; Luo H
Front Cell Infect Microbiol; 2017; 7():85. PubMed ID: 28361043
[TBL] [Abstract][Full Text] [Related]
39. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade.
Lengyel E; Wang H; Gum R; Simon C; Wang Y; Boyd D
Oncogene; 1997 May; 14(21):2563-73. PubMed ID: 9191056
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors.
Goodfellow IG; Evans DJ; Blom AM; Kerrigan D; Miners JS; Morgan BP; Spiller OB
J Virol; 2005 Sep; 79(18):12016-24. PubMed ID: 16140777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
